F. Okmen Et Al. , "The role of fetal fibronectin and plasminogen activator inhibitor 1 biomarkers in antenatal prediction of placenta accreta spectrum," Journal of Obstetrics and Gynaecology , vol.42, no.6, pp.2008-2012, 2022
Okmen, F. Et Al. 2022. The role of fetal fibronectin and plasminogen activator inhibitor 1 biomarkers in antenatal prediction of placenta accreta spectrum. Journal of Obstetrics and Gynaecology , vol.42, no.6 , 2008-2012.
Okmen, F., Ekici, H., Koca, E., Sucu, V., Ogur, M., & Narin, R., (2022). The role of fetal fibronectin and plasminogen activator inhibitor 1 biomarkers in antenatal prediction of placenta accreta spectrum. Journal of Obstetrics and Gynaecology , vol.42, no.6, 2008-2012.
Okmen, Firat Et Al. "The role of fetal fibronectin and plasminogen activator inhibitor 1 biomarkers in antenatal prediction of placenta accreta spectrum," Journal of Obstetrics and Gynaecology , vol.42, no.6, 2008-2012, 2022
Okmen, Firat Et Al. "The role of fetal fibronectin and plasminogen activator inhibitor 1 biomarkers in antenatal prediction of placenta accreta spectrum." Journal of Obstetrics and Gynaecology , vol.42, no.6, pp.2008-2012, 2022
Okmen, F. Et Al. (2022) . "The role of fetal fibronectin and plasminogen activator inhibitor 1 biomarkers in antenatal prediction of placenta accreta spectrum." Journal of Obstetrics and Gynaecology , vol.42, no.6, pp.2008-2012.
@article{article, author={Firat Okmen Et Al. }, title={The role of fetal fibronectin and plasminogen activator inhibitor 1 biomarkers in antenatal prediction of placenta accreta spectrum}, journal={Journal of Obstetrics and Gynaecology}, year=2022, pages={2008-2012} }